Alembic intros generic Aubagio
Generic Aubagio treats relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, in adults.
Alembic is introducing teriflunomide tablets, the generic of Sanofi-Aventis’s Aubagio.
Teriflunomide is a pyrimidine synthesis inhibitor indicated for treating relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, in adults.
[Read more: Alembic rolls out generic Hygroton]
Alembic’s generic product comes in dosages of 7 mg and 14 mg in 30-ct. bottles.